HomeOpen Access NewsDrug Development

Drug Development

Understanding the true impact of chronic pain

Chronic pain can affect a person’s life in a myriad of ways. Asal Shirazi BEM, Founder of the Autoimmune Support & Awareness Foundation (ASA Foundation), talks us through some of the conditions associated with chronic pain and the advancements in pain management.

Germany becomes one of the first European countries to legalise cannabis

Germany has made plans to legalise cannabis, which could create up to 27,000 new jobs and save around about 4.7 billion euros.

Do you really need to be taking paracetamol?

Paracetamol is Britain’s most trusted painkiller with the average person taking up to 70 paracetamol per year, however there are safety issues.

A blueprint for the UK Cannabis Industry

Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors LLP, share their views on a blueprint for the UK Cannabis Industry.

Diabetes education to protect tomorrow

Prof Andrew Boulton, President, International Diabetes Federation, calls for more to be done to improve access to diabetes education.

Tuberculosis drug regimens and their efficacies

Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.

What’s the connection between menopause and weight gain?

The relation between menopause, BMI, hormones and weight gain is a complex one that many going through menopause don't really understand here menopause expert Dr Deborah Lee explains.

Benefits of animal vaccination for animals & people

Roxane Feller, Secretary General of AnimalhealthEurope, helps us understand the benefits of animal vaccination for both animals and people.

What are the mental and physical health benefits of essential oils?

Essential oils have been used for centuries for their medicinal properties. However, scientists have only now started studying and exploring the potential benefits of essential oils.

Type 1 diabetes treatment finds new target

A new route to the regeneration of insulin in the pancreatic stem cells indicates a major breakthrough for Types 1 and 2 Diabetes therapies.

Acoustic Cluster Therapy – A novel ultrasound-mediated drug delivery platform for therapeutic enhancement across multiple diseases

Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.

Beating lung cancer with the AI edge

Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.

UK Cannabis Industry – the next Scottish Whisky

Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?

Thailand gives out one million free cannabis plants to promote legalisation

One million homes will be given cannabis plants across Thailand, to mark the legalisation and attract foreign tourists – to be used for ‘medicinal purposes’ only.

NIH begins clinical trial for Epstein-Barr virus vaccine

The clinical trial will test an Epstein-Barr virus vaccine developed by Novavax, one of just two attempts in over a decade.

Study explores cheaper way to produce compounds for pharmaceuticals

Researchers have developed a new tool that can make it easier and cheaper to fabricate the compounds needed for pharmaceuticals.

Ukrainian patients lose access to multiple sclerosis drug trial

Biotechnology giant Roche warns that multiple sclerosis (MS) drug trials are compromised in Ukraine - with patients losing access to crucial treatment.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders